Sigita Plioplys, M.D.
|
|
- Raymond Blake
- 7 years ago
- Views:
Transcription
1 Psychiatric Issues in Dravet Syndrome: Focusing on Medications Sigita Plioplys, M.D. Head, Pediatric Neuropsychiatry Clinic Dep. of Child and Adolescent Psychiatry Ann and Robert H. Lurie Children s Hospital of Chicago Associate Professor Feinberg School of Medicine, Northwestern University
2 Disclosure Nothing to disclose
3 Psychiatric Treatment Evidence based treatment integrates best research evidence with clinical expertise and patient values No research studies have been published on: Psychopathology in children with Dravet syndrome Treatment options Long term psychiatric outcome
4 Problems with Psychiatric Treatment in Dravet Syndrome No evidence based data are available to guide psychiatric treatment in children with Dravet syndrome Treatment is guided by the clinical experience and expertise of a child psychiatrist Shortage of child psychiatrists who have experience with this disorder
5 Psychiatric Treatment It starts with an accurate identification of psychiatric problems and associated impairment Treatment targets the most impairing symptom/problem in the context of seizure presentation and their management Seizure control is a priority
6 Psychiatric Treatment Psychiatric problems: Multiple emotional and behavioral problems leading to multiple comorbid diagnoses Psychiatric and cognitive comorbidities Time course association Cognitive impairment predicts the severity of psychiatric problems Impact of seizures and antiepileptic medications on cognitive and psychiatric symptoms
7 Psychiatric Diagnoses Psychiatric diagnosis is reached after a comprehensive clinical assessment: Clinical interview with the parents and children Clinical observation of the patient Information from the teachers Review of neurological and psychological testing Diagnosis is based on the standard DSM-5 criteria
8 Most Common Psychiatric Problems and Diagnoses Developmental/cognitive Intellectual disability, language and learning disorders Inattentiveness, hyperactivity, impulsivity ADHD Impairment in executive functioning Social skills deficits Language disorders, ID, ASD, ADHD
9 Most Common Psychiatric Problems and Diagnoses Aggression Learning disorders, ID, ASD, ADHD, ODD, DBD, mood disorders Mood problems Depression Anxiety
10 Psychiatric Treatment Medications alone are not as effective as in combination with other interventions: special education, speech, individual, family therapy, and parent training
11 Psychiatric Treatment Specific pharmacological treatment is not available for: Developmental delay Social skills deficits Special education, developmental and behavioral therapies, social skills training, ABA
12 Psychopharmacological Treatment Distractibility, hyperactivity, impulsivity (ADHD) Executive function impairment Aggression Mood problems
13 ADHD Treatment #1. A stimulant: usually methylphenidate (Ritalin, Metadate, Concerta, Focalin, Daytrana) #2. The other stimulant: usually amphetamines (Adderall, Vyvance) #3. Atomoxetine (Strattera) #4. An alpha agonists: guanfacine (Tenex, Intunive), clonidine (Catapres)
14 ADHD Treatment FDA-approved product labeling for all stimulant products states that there is clinical evidence that stimulants may lower the convulsive threshold in patients with prior seizures The FDA warning recommends that stimulants should be discontinued in the presence of seizures
15 ADHD Treatment Methylphenidate (MPH) is the most studied drug that has shown good short-term efficacy: 2 controlled studies available, both found MPH to be safe and effective in children with well controlled seizures Controlled trials have noted significant improvements in ADHD symptoms without an exacerbation of seizures No studies to report major interactions between AEDs and MPH
16 ADHD Treatment Stimulants are effective and safe first-line medications for ADHD The selection of a specific stimulant should be based on the patient s clinical presentation, clinician s experience, and parent s choices
17 Adderall XR Warning FDA - August 2004 Sudden death has been reported in association with amphetamine treatment at usual doses in children with structural cardiac abnormalities. Canada Pulled Adderall XR 2005 back on market no evidence for increased cardiac risk
18 FDA Stimulant Warnings Amphetamine and Methylphenidate Sudden death reported in patients with structural cardiac abnormalities or other serious heart problems. Careful family and personal history needed, further cardiac evaluation only if indicated No routine pre-tx cardiac eval indicated unless known disorder or cardiac symptoms Hypertension (primarily concern in adults) Hallucinations Aggression and hostility
19 Stimulants and Drug Abuse No evidence for stimulant-induced increase in drug abuse Successful ADHD treatment reduces drug abuse in adolescence Stimulant intake must be supervised and monitored by parents
20 ADHD Treatment Stimulant with a shorter duration (6-8 hours vs hours) of action may help to prevent potential delay in sleep onset and disruption of sleep pattern. Significantly decreased weight may affect AED s serum levels. Weight needs to be monitored at each appointment.
21 ADHD Treatment: Growth Studies inconsistent re height Monitor height and weight Adjust foods and mealtimes Catch-up growth when off medication Temporary height deficits may be related to ADHD Some studies ADHD kids bigger than average pre-medication
22 ADHD Treatment: Atomoxetine The second-line of treatment: May affect liver function due to the polypharmacy with AEDs No interactions with any of the AEDs have been reported On direct comparison, ATX is less effective than Adderall XR and MPH Some non-responders to stimulants respond to ATX
23 Guanfacine (Tenex) and Clonidine (Catapress) The third-line of treatment: Guanfacine is less sedating than clonidine Clonidine produces more: rebound and withdrawal blood pressure reduction shorter acting - must use four times per day transdermal Patch (5 days)
24 Psychiatric Treatment Unproven ADHD treatments Treatment of food allergies Caffeine Megavitamins Biofeedback Eye-tracking therapies Chiropractic manipulations BrainGym and other brain training programs
25 Aggression Irritability Rule medication side effects Defiance Communication problems, anxiety, impulsivity Self-injurious behaviors Sensory issues, boredom, negative attention seeking Aggression towards others Usually caused by multiple factors Functional behavioral analysis
26 Psychiatric Treatment Aggression Treatment targets potential triggers: Impulsivity, hyperactivity treatment as in ADHD Anxiety, depression SSRIs, mood stabilizers No clear triggers or resistant to the above mentioned treatments - atypical neuroleptics
27 Aggression/tantrums/selfinjury SSRIs Atypical antipsychotics Typical antipsychotics Traditional mood stabilizers Alpha agonists Glutamatergic agents
28 Selective Serotonine Reuptake Inhibitors (SSRIs) Increase serotonin levels in the brain: Fluoxetine (Prozac) Sertraline (Zoloft) Escitalopram (Lexapro) Citalopram (Celexa) Fluvoxamine (Luvox) Paroxetine (Paxil)
29 SSRIs Most common side effects: Nausea, headaches (short duration) Extremely rare side effects: Bleeding, jitteriness, agitation, sleep disturbance FDA Black Box warning about increased suicidal thinking in selected population.
30 SSRIs Extremely rare side effects: Cardiovascular side effects, with a reported incidence of less than % SSRIs inhibit cardiac and vascular sodium, calcium and potassium channels and prolong QT intervals. A number of large studies of patients without known pre-existing heart disease have reported no EKG changes related to SSRI use
31 SSRIs There are a number of potential drugdrug interactions between the various individual SSRIs and antiepileptic medications Most of these arise due to SSRI ability to inhibit liver enzymes (P450 cytochromes) and slow down the metabolism of the antiepileptics potentially resulting in increased levels
32 Atypical Neuroleptics Increase dopamine, serotonin, and histamine levels in the brain Off label use for aggression, irritability, tics, mood disorders, and psychosis Metabolic and neurological complications with chronic use
33 Atypical Antipsychotics Currently have the strongest evidence base of any pharmacologic treatment of irritability, aggression, rigid preoccupations in ASDs FDA approval for: Risperidone: irritability and associated dysfunctional behaviors associated with autistic disorder in 5-16 year olds Aripiprazole: irritability associated with autistic disorder in 6-17 year olds
34 Atypical Antipsychotics The RUPP study showed significant positive responses for stereotypical and repetitive behaviors vs placebo Considered as second line agents for treatment refractory ASD cases prior to the recent Citalopram study
35 Atypical Neuroleptics Risperidone (Risperdal) Olanzapine (Zyprexa) Quetiapine (Seroquel) Aripiprazole (Abilify) Ziprasidone (Geodon) Paliperidone (Invega)
36 Atypical Neuroleptics Most common side effects: Weight gain and increased body mass index Increased lipids (cholesterol) Increased blood glucose and risk for type II diabetes Sedation Drooling
37 Atypical Neuroleptics Extremely rare side effects: Abnormal muscle movements (Dystonia) Parkinson like symptoms Discharges from the breasts in boys and girls Increased seizures Neuroleptic-malignant syndrome (high fever, kidney failure, destruction of muscles) Hypothyroidism
38 Atypical Neuroleptics Extremely rare side effects: Changes in heart rhythm (prolongation of qt) that may cause ventricular arrhythmias Physical activation (akathesia - increased need to move)
39 Pediatric Clinical Use - Tidbits Akathisia risk appears equal to adult rates Dyskinesias are frequently reversible Tardive dyskinesia risk appears ~1/2 that of adults (annualized incidence rate of 0.04%) Cases of neuroleptic malignant syndrome have been reported with SGAs Case reports of new onset diabetes
40 Tidbits - continued Hyperprolactinemia is dose-dependant, reduces over time and resolves when medication is stopped Only Olanzapine has been associated with sig increase in glucose, insulin, lipids and LFTs in RCTs
41 Relative Risk of Side Weight Gain OLZ>Ris QTP>HAL> ARP>ZIP Prolactin Elevation Effects PAL>RIS>HAL>OLZ>ZIP>QTP>CLZ>ARP Sedation OLZ>RIS>QTP>ZIP>ARP
42 Typical Antipsychotics Multiple RCTs beginning in the 1960 s demonstrated benefit, especially with Haloperidol, in alleviating aggression/tantrums/self-injury in ASDs However, there were high rates of acute dystonic reactions, drug-induced and withdrawal dyskinesias, and increased risk for seizures leading to using atypicals once these drugs became available Typicals are now generally reserved for individuals with severe, treatment-resistant symptoms
43 Glutamatergic Agents Amantadine (NMDA antagonist) single small DBPC trial showed improvement in hyperactivity and inappropriate speech domains of the ABC-CV Memantine (NMDA antagonist) and D- cycloserine (NMDA partial-agonist) have shown positive results in small, open trials
44 Traditional Mood Stabilizers Lithium Valproate Carbamazepine
45 Take Home Message Evidence based data on safe and effective pharmacological treatment options for psychiatric problems in children with Dravet syndrome are not available Treatment studies are desperately needed to identify safe and effective medications for this patient population Currently, pharmacological treatment decision depends only on the experience and expertise of a treating psychiatrist's and parental values
Medications Used in the Management of Disruptive Behavior Disorders
The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.
More informationComorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014
Comorbid Conditions in Autism Spectrum Illness David Ermer MD June 13, 2014 Overview Diagnosing comorbidities in autism spectrum illnesses Treatment issues specific to autism spectrum illnesses Treatment
More informationOverview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
More informationPSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
More informationMEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS. Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D.
MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D. Introduction Tourette Syndrome (TS) or Tourette s Disorder
More informationThe following is a sample of psychotropic drug warnings that drug regulatory agencies
Chronology of International Drug Regulatory Agency Warnings about Psychotropic Drugs The following is a sample of psychotropic drug warnings that drug regulatory agencies around the world have issued.
More informationAutism Spectrum Disorders and Comorbid Behavioral Health Symptoms
Autism Spectrum Disorders and Comorbid Behavioral Health Symptoms Cynthia King, MD Child and Adolescent Psychiatrist Associate Professor of Psychiatry UNMSOM Psychopharmacologic and Alternative Medicine
More informationPsychopharmacotherapy for Children and Adolescents
TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners
More informationBipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:
Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic
More informationMedications for Huntington s Disease Vicki Wheelock, M.D.
Medications for Huntington s Disease Vicki Wheelock, M.D. Director, HDSA Center of Excellence at UC Davis June 4, 2013 Outline Introduction and disclaimers Medications for cognitive symptoms Medications
More informationATYPICALS ANTIPSYCHOTIC MEDICATIONS
The atypical antipsychotics are a class of drugs that are used to treat a number of behavioral health disorders, including schizophrenia, other psychotic disorders, mood disorders, and behavioral agitation
More informationObsessive Compulsive Disorder: a pharmacological treatment approach
Obsessive Compulsive Disorder: a pharmacological treatment approach Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital
More informationUnderstanding Antipsychotic Medications
Understanding Antipsychotic Medications NARSAD RESEARCH National Alliance for Research on Schizophrenia and Depression 60 Cutter Mill Road, Suite 404 Great Neck, NY 11021 516-829-0091 1-800-829-8289 516-487-6930
More informationPsychotic Disorder. Psychosis. Psychoses may be caused by: Examples of Hallucinations and Delusions 12/12/2012
Psychosis Psychotic Disorder Dr Lim Boon Leng Psychiatrist and Medical Director Dr BL Lim Centre For Psychological Wellness Tel: 64796456 Email: info@psywellness.com.sg Web: www.psywellness.com.sg A condition
More informationMedication Side Effects:
Medication Side Effects: Staying Healthy While on Psychotropic Medications Megan Maroney PharmD, BCPP Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers the State University of New Jersey
More informationTreatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers
Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity
More informationADHD PRACTISE PARAMETER. IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY
ADHD PRACTISE PARAMETER IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY Similar type of idea Similar document Similar document AACAP document Neurobiological condition
More informationNew Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care
New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care Post-Test/Rationale EDUCATIONAL OBJECTIVES Upon completion of this activity, participants
More informationClinical Summary of Pediatric Metabolic AERS Reports. Judith Cope, MD, MPH Office of Pediatric Therapeutics/FDA
Clinical Summary of Pediatric Metabolic AERS Reports Judith Cope, MD, MPH Office of Pediatric Therapeutics/FDA 1 Clinical Summary of Pediatric Metabolic AERS Reports: Atypical Antipsychotics n=100 reports;
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationRecognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
More informationBelow, this letter outlines [patient name] s medical history, prognosis, and treatment rationale.
[Date] [Name of Contact] [Title] [Name of Health Insurance Company] [Address] [City, State, Zip Code] Insured: [Patient Name] Policy Number: [Number] Group Number: [Number] Diagnosis: [Diagnosis and ICD-9-CM
More informationMOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D.
MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D. BIPOLAR AFFECTIVE DISORDER (BAD) General Assessment is challenging Input important Change in level of functioning
More informationI. The Positive Symptoms...Page 2. The Negative Symptoms...Page 2. Primary Psychiatric Conditions...Page 2
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Assessment & Treatment of Psychosis Developed March 1, 2003 Revised September 21,
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationStimulants and Nonstimulants for ADHD
Stimulants and Nonstimulants for ADHD Stimulants Adderall and Adderall XR (amphetamine mixtures) Concerta (methylphenidate, extended release) Daytrana (methylphenidate topical patch) Dexedrine and Dexedrine
More informationPsychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.
Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review
More informationTherapies for Children With Autism Spectrum Disorders. A Review of the Research for Parents and Caregivers
Therapies for Children With Autism Spectrum Disorders A Review of the Research for Parents and Caregivers Is This Guide Right for the Child in My Care? Yes, if: The child you care for is between 2 and
More information1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care
PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When
More informationChapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of
Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of antipsychotic agents Identify common adverse effects
More informationBRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS
BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationPsychotropic Medication Reference Chart
Psychotropic Medication Reference Chart Appendix 4.14 This chart is not an all-inclusive list of medications. If you have a question regarding the classification of a medication you may consult websites
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationA Guide to Tourette Syndrome Medications by John T. Walkup M.D.
llllllllllllllll A TSA MEDICAL PUBLICATION A Guide to Tourette Syndrome Medications by John T. Walkup M.D. This publication is intended to provide information about Tourette Syndrome, its management and
More informationJane Marie Sulzle, DNP, CNS, MS PrairieCare Medical Group, Edina
Children, Mental Health, and Psychiatric Medication: Empowering parents with information on how to talk to their children about medication and how the medication may impact school performance. Jane Marie
More informationA BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES
INTRODUCTION A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES Individuals with intellectual disabilities are not uncommonly prescribed psychotropic medications.
More informationContemporary Psychiatric-Mental Health Nursing. Assessing the Effectiveness of Medications. Administering Medications
Contemporary Psychiatric-Mental Health Nursing Chapter 32 Psychopharmacologic Nursing Interventions Assessing the Effectiveness of Medications Include how well the medications are helping the client to
More informationBasic Principles in the Pharmacologic Management of ADHD
Child & Adolescent Psychiatry and Behavioral Medicine Center Basic Principles in the Pharmacologic Management of ADHD Overview Therapy may be indicated in ADHD to address organizational skills deficits
More informationBehavioral and Pharmacologic Treatment of Aggression in Children With Autism
http://www.cmp.com/ http://www.psychiatrictimes.com/ Behavioral and Pharmacologic Treatment of Aggression in Children With Autism By Craig A. Erickson, M.D., Naomi B. Swiezy, Ph.D., Kimberly A. Stigler,
More informationSummary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)
EMA/303592/2015 Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Pharmathen, which details the measures
More informationCOMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA
COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA Manic depressive illness is a biological brain disorder that produces significant alterations of mood and psychosis. Mania in the elderly occurs
More informationThe core symptoms of ADHD, as the name implies, are inattentiveness, hyperactivity and impulsivity. These are excessive and long-term and
Attention Deficit Hyperactivity Disorder What is Attention Deficit Hyperactivity Disorder? The core symptoms of ADHD, as the name implies, are inattentiveness, hyperactivity and impulsivity. These are
More informationPharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence
Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationMedicines for Treating Depression. A Review of the Research for Adults
Medicines for Treating Depression A Review of the Research for Adults Is This Information Right for Me? Yes, if: A doctor or other health care professional has told you that you have depression. Your doctor
More informationAutism Spectrum Disorders and Co-Occurring Mental Health Conditions
Autism Spectrum Disorders and Co-Occurring Mental Health Conditions Sydney Rice, MD, MS University of Arizona LEND Erika Ryst, M.D. University of Nevada LEND October 5, 2015 Overview Children with autism
More informationEvaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price
Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price Contents Our Recommendations...........................................
More informationMedications for bipolar disorder
Medications for bipolar disorder Findings from Australian National Survey of Mental Health and Wellbeing (Mitchell et al, 2004) In 12 months, only one-third saw a mental health professional 40% received
More informationPsychotropic Medication
Page 1 T I P S F O R P R A C T I C E Psychotropic Medication Psychotropic medications are symptomatic medications that affect attention, emotions, or behaviors. Communication between the physician, NDHHS
More informationMedication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center
Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):
More informationWhat are the best treatments?
What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,
More informationAlgorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationTreating Mood and Anxiety Disorders in Children & Adolescents
Treating Mood and Anxiety Disorders in Children & Adolescents Daniel S. Pine, MD Section on Development & Affective Neuroscience Disclosures: Conflicts Sources of Research Support National Institute of
More informationDual Diagnosis in Treatment
Dual Diagnosis in Treatment Presented by: Dr. John E. Simon Psychiatrist, Vinland Center 1 John E. Simon, M.D. President, Creative Psychopharmacology Board Certified in Psychiatry Added Qualifications
More informationAntipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers
SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this
More informationNorth Pacific Epilepsy Research 2311 NW Northrup Street Suite #202 Portland, Oregon 97210 Tel: 503-291-5300 Fax: 503-291-5303
North Pacific Epilepsy Research 2311 NW Northrup Street Suite #202 Portland, Oregon 97210 Tel: 503-291-5300 Fax: 503-291-5303 Post-Traumatic Stress Disorder (PTSD) Post-traumatic stress disorder (PTSD)
More informationTourette syndrome and co-morbidity
Tourette syndrome and co-morbidity Nanette M.M. Mol Debes, M.D., Ph.D. Tourette clinic, Herlev University Hospital, Denmark Outline of presentation Research project Herlev University Hospital Denmark Prevalence
More informationHandout 2 List of medications used to treat mental illness
Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following
More informationClinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder
Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder AACAP Official Action: OUTLINE OF PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS WITH ADHD
More informationChildren, Adolescents and Psychiatric Medication
Children, Adolescents and Psychiatric Medication Prepared by: Lee Combrinck-Graham, MD, Carolyn Crowder, PhD, Judith Pentz, MD, and Natalie Sadler, MD When your child is misbehaving do people ask you or
More informationHD 101 for newcomers. Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center
HD 101 for newcomers Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center The information provided by speakers in workshops, forums, sharing/networking sessions and any
More informationChildhood Rage: Diagnosis and Treatment Strategies for Severe Mood Dysregulation - Part 2: Diagnosis and Treatment
Liberty University DigitalCommons@Liberty University Faculty Publications and Presentations Center for Counseling and Family Studies 2013 Childhood Rage: Diagnosis and Treatment Strategies for Severe Mood
More informationA Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.
Bipolar disorder Bipolar (manic-depressive illness) is a recurrent mode disorder. The patient may feel stable at baseline level but experience recurrent shifts to an emotional high (mania or hypomania)
More informationDEMENTIA EDUCATION & TRAINING PROGRAM
The pharmacological management of aggression in the nursing home requires careful assessment and methodical treatment to assure maximum safety for patients, nursing home residents and staff. Aggressive
More informationNICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
More informationMoody Kids, Bipolar Disorder, and Medication Treatment Strategies. Learning Objectives. Mood Episodes. Irritability and Anger are Nonspecific Symptoms
Moody Kids, Bipolar Disorder, and Medication Treatment Strategies May 6, 2016 Dara Sakolsky, MD, PhD Associate Medical Director, STAR Clinic Assistant Professor of Psychiatry University of Pittsburgh Medical
More informationTreating Children with Anxiety and Bipolar Disorder. Ellen Leibenluft, M.D.
Treating Children with Anxiety and Bipolar Disorder Ellen Leibenluft, M.D. Chief, Section on Bipolar Spectrum Disorders Emotion and Development Branch National Institute of Mental Health National Institutes
More informationGMMMG Interface Prescribing Subgroup. Shared Care Template
GMMMG Interface Prescribing Subgroup Shared Care Template Shared Care Guideline for Selective Serotonin Reuptake Inhibitors (SSRIs) for the treatment of Obsessive Compulsive Disorder (OCD) and Body Dysmorphic
More informationWhat is ADHD/ADD and Do I Have It?
What is ADHD/ADD and Do I Have It? ADHD Definition and Symptoms Adults with ADHD Possible Coexistent Conditions Medications and Treatments Additional Resources Works Cited What is Attention Deficit Hyperactivity
More informationNew Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine
New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept
More informationMCPS Special Education Parent Summit
MCPS Special Education Parent Summit May 17, 2014 Rockville High School 2100 Baltimore Road Rockville, MD 20851 When ADHD Is Not ADHD: ADHD Look-Alikes and Co-occurring Disorders David W. Holdefer MCPS
More informationPSYCHOTROPIC MEDICATIONS
PSYCHOTROPIC MEDICATIONS 644.3 Bipolar Disorder This Instructor s Guide contains: Brief Description, Objectives, Discussion Questions, Pretest, Post-test, Answer Keys and Glossary for this program, Psychotropic
More informationBipolar disorder. Understanding NICE guidance
Understanding NICE guidance Information for people who use NHS services Bipolar disorder NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments
More informationADHD: what treatments work?
Patient information from the BMJ Group ADHD: what treatments work? Caring for a child who has attention deficit hyperactivity disorder (ADHD) can put a strain on you and your family. If your child has
More informationStep 4: Complex and severe depression in adults
Step 4: Complex and severe depression in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationIrritability and DSM-5 Disruptive Mood Dysregulation Disorder (DMDD): Correlates, predictors, and outcome in children
Irritability and DSM-5 Disruptive Mood Dysregulation Disorder (DMDD): Correlates, predictors, and outcome in children Ellen Leibenluft, M.D. Chief, Section on Bipolar Spectrum Disorders National Institute
More informationTreatment of Behavioral Health Disorders in Adolescents: Depression, Bipolar Disorder, Schizophrenia
Treatment of Behavioral Health Disorders in Adolescents: Depression, Bipolar Disorder, Schizophrenia ELINORE F. MCCANCE-KATZ, MD, PHD CHIEF MEDICAL OFFICER SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION
More informationInformation on Treating ADHD
Developed by the health care professionals of Child & Adolescent Mental Health Programs and reviewed by the Department of Learning and Development. ADHD: Being Informed Attention Deficit Hyperactivity
More informationDSM 5 AND DISRUPTIVE MOOD DYSREGULATION DISORDER Gail Fernandez, M.D.
DSM 5 AND DISRUPTIVE MOOD DYSREGULATION DISORDER Gail Fernandez, M.D. GOALS Learn DSM 5 criteria for DMDD Understand the theoretical background of DMDD Discuss background, pathophysiology and treatment
More informationChronic mental illness in LTCF. Chronic mental illness. Other psychiatric disorders.
Chronic mental illness in LTCF Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Chronic mental illness 1. Schizophrenia and Schizoaffective disorder. 2. Bipolar disorder (Type 1 and
More informationDepression in the Elderly: Recognition, Diagnosis, and Treatment
Depression in the Elderly: Recognition, Diagnosis, and Treatment LOUIS A. CANCELLARO, PhD, MD, EFAC Psych Professor Emeritus and Interim Chair ETSU Department of Psychiatry & Behavioral Sciences Diagnosis
More informationPost-traumatic stress disorder overview
Post-traumatic stress disorder overview A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationAutisme Spectrum Disorder & AHDH Mutually Exclusive?!? a Clinical Issue
Autisme Spectrum Disorder & AHDH Mutually Exclusive?!? a Clinical Issue Rutger Jan van der Gaag MD PhD UMC St. Radboud / Karakter UCN University Department Child & Adolescent Psychiatry Nijmegen, the Netherlands
More informationLearning Disabilities: ADHD/ADD. Dr. Wilfred Johnson September 29, 2005
Learning Disabilities: ADHD/ADD Dr. Wilfred Johnson September 29, 2005 Prevalence of ADHD/ADD ADHD/ADD is the most common childhood psychiatric disorder. Conservative estimate of prevalence is 2%; liberal
More informationPSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency
More informationTREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
More informationTourette Syndrome (Chronic Multiple Tic Disorder, Gilles de la Tourette Syndrome) Eva Mauer, M.D. and Joanne M. Weigel, M.D.
CALIFORNIA DEPARTMENT OF EDUCATION DIAGNOSTIC CENTER, SOUTHERN CALIFORNIA Tourette Syndrome (Chronic Multiple Tic Disorder, Gilles de la Tourette Syndrome) Eva Mauer, M.D. and Joanne M. Weigel, M.D. Tourette
More informationBIPOLAR DISORDER IN PRIMARY CARE
E-Resource January, 2014 BIPOLAR DISORDER IN PRIMARY CARE Mood Disorder Questionnaire Common Comorbidities Evaluation of Patients with BPD Management of BPD in Primary Care Patient resource Patients with
More informationHandy charts to help people compare the medications for mental health conditions
Handy charts Handy charts to help people compare the medications for mental health conditions Contents: 1. Acute Psychiatric Emergency 2. ADHD (Attention Deficit Hyperactivity Disorder) 3. Alcohol Dependence
More informationBehavioral Health Diagnoses, Symptoms, and Interventions for Children Ages 4 and older
Diagnosis Typical symptoms Behavioral interventions known to work (Evidence-informed; Manualized) *Descriptions provided below Trauma-related disorders Post-traumatic stress disorder --------------------------
More informationPaxil/Paxil-CR (paroxetine)
Generic name: Paroxetine Available strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 10 mg/5 ml oral suspension; 12.5 mg, 25 mg, 37.5 mg controlled-release tablets (Paxil-CR) Available in generic: Yes, except
More informationChapter 13 433-end Name Period Date. MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.
Chapter 13 433-end Name Period Date MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) Stress-inoculation therapy is one type of therapy. A) cognitive
More informationASSESSMENT AND MANAGEMENT OF PSYCHOSIS IN PERSONS WITH DEMENTIA
ASSESSMENT AND MANAGEMENT OF PSYCHOSIS IN PERSONS WITH DEMENTIA Overview: Psychosis is a common clinical feature of dementia. Hallucinations and delusions are the two most common types of psychotic symptoms
More informationDementa Formulary Guidance [v1.0]
Dementa Formulary Guidance [v1.0] 1. Introduction These Guidelines are intended for routine use. However there will be instances where they are not suitable for the patient you are managing, where more
More informationATTENTION DEFICIT HYPERACTIVITY DISORDER AND TUBEROUS SCLEROSIS COMPLEX
ATTENTION DEFICIT HYPERACTIVITY DISORDER AND TUBEROUS SCLEROSIS COMPLEX What is ADHD? Attention Deficit Hyperactivity Disorder (ADHD) is a common neurobehavioral disorder. It is usually first diagnosed
More informationAttention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder Spring 2015 Continuing Education John Erramouspe, PharmD, MS Idaho State University College of Pharmacy 208-282-3019 johnerra@pharmacy.isu.edu I have no relevant
More informationLeading European Psychiatrists, Janssen-Cilag and Scientific Fraud
Concerta for adults Leading European Psychiatrists, Janssen-Cilag and Scientific Fraud December 9, 2011 How could leading European psychiatrists claim that the ADHD drug Concerta was safe and worked fantastically
More informationAmphetamines Addiction
Introduction Amphetamines, which are classified as stimulants, work by using the dopamine reward system of the brain. When these drugs are used, the user s central nervous system is simulated which causes
More information